Wuhan Zonke Optoelectronic Technology Co., Ltd.
News Center
Wuhan Zhongke made its debut at the Bio-Innovation Summit, showcasing new breakthroughs in radio-frequency technology.
Release time:2025-08-19

On August 19, at the Bio-Innovation Summit and Elite Talent Salon hosted by the Wuhan National Bio-Industry Base, Wuhan Zhongke was invited to attend and deliver a keynote address.

As a leading enterprise in China’s energy‑based therapeutic device sector, Wuhan Zhongke focuses on RF technology R&D and boasts a diverse product portfolio that includes flagship and innovative offerings such as Shumin Zhi Xing, Fu Ling Chun, Thermage Cool, and Jin Ba.


The company is the world’s only enterprise to master five AI‑powered, large‑scale RF models, holding 33 related invention patents. Its products are widely deployed in China’s top 100 hospitals, with over ten million clinical cases. Looking ahead, Wuhan Zhongke will continue to ramp up R&D investment, solidify its leading position in the AI‑enabled RF field, and strive to become a global unicorn in the healthcare sector.
Related News